Comparing a new diabetes combination to standard care for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests if a once-daily injectable combination (iGlarLixi) helps control blood sugar better than usual care for people with type 2 diabetes who are already taking diabetes pills. It aims to find a more effective treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with type 2 diabetes.
- You have been taking 1 to 3 diabetes pills for at least 3 months.
- Your HbA1c (average blood sugar over 3 months) is between 7.5% and 11%.
- Your doctor thinks you need to start an injectable diabetes medicine.
- You are not pregnant, breastfeeding, or plan to become pregnant during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination pen (insulin degludec with liraglutide) for people with type 2 diabetes whose blood sugar is not well controlled on metformin alone or with one other pill. The goal is to see if the combination improves blood sugar control safely.
This study tests a new once-daily injection (LC-Z300-01) to see if it can lower blood sugar safely in people with type 2 diabetes. It may be a good option if your current diabetes medications aren't controlling your blood sugar as well as you'd like.
This study tests a new once-daily insulin (GZR4) against an approved insulin (degludec) in people with type 2 diabetes to see how well it controls blood sugar. You may qualify if you are already using a stable dose of background insulin.
This study tests how well different diabetes medications work after a brief period of intensive insulin therapy. It may help you find a simpler, effective treatment plan tailored to your needs.
This study tests a combination insulin/GLP-1 medicine (iGlarLixi) with continuous glucose monitoring to see how well it controls blood sugar in Chinese adults with type 2 diabetes. It may help those whose current pills are not working enough.
This study tests whether a new injection that combines insulin with liraglutide works better than standard premixed insulin for people with type 2 diabetes. It aims to improve blood sugar control and simplify treatment.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.